Back to News
Market Impact: 0.25
Bristol Myers Squibb Yields Over 4%. Can Its Dividend Survive 2027?
Source: 247wallst.com
Healthcare & BiotechCompany FundamentalsCorporate Guidance & OutlookCapital Returns (Dividends / Buybacks)Credit & Bond Markets
Bristol Myers Squibb is expected to lose $1.5 billion to $2 billion in sales as a blockbuster blood thinner faces an unspecified change, while its debt burden remains. The article flags implications for retirees relying on the company's payout ahead of 2027 but provides no dividend figures or further details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment
BMY-0.55
More News
- Bristol Myers Squibb presents 56-week Camzyos trial data
- Tech stock rout, driven by US AI fears, continues in Asian trading
- Elon Musk once said the Cybertruck would be Tesla’s ‘best product ever.’ Now he’s winding down production
- Fox completes its $22B acquisition of Roku
- Elanco Shares Jump After Q3 Beat and Outlook Raise
- Paraguay’s Santiago Pena under arrest, new president Pedro Alliana sworn in